Preclinical activity of the type II CD20 antibody GA101 (obinutuzumab) compared with rituximab and ofatumumab in vitro and in xenograft models.
| Image |  |
|---|---|
| Description | scientific article published on 19 July 2013 |
| Author/s |
author: Charles Dumontet Minh Ngoc Duong |
| Publication date | July 19, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |